FCCL maker Taiflex Scientific expects its revenues to slide 13.5% sequentially to NT$2.1-2.7 billion (US$69.29-89.08 million) in the first quarter of 2014, with an operating margin of 9-13% and a gross margin of 19-23%, according to the company.
The article requires paid subscription. Subscribe Now